NCT00246922View on ClinicalTrials.gov

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

October 31, 2007

Conditions
Bronchial Asthma
Interventions
DRUG

Roflumilast

Trial Locations (1)

Unknown

Nycomed Japan and Mitsubishi Tanabe Pharma Corporation, Osaka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Mitsubishi Tanabe Pharma Corporation

INDUSTRY

lead

AstraZeneca

INDUSTRY